Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Appendix 3B

25 Feb 2013 07:51

RNS Number : 5611Y
Oilex Limited
25 February 2013
 



 

 

 

 

 

 

25 February 2013

 

 

 

 

Dear Sirs

 

Appendix 3B

 

We enclose an Appendix 3B detailing the issue of the following unlisted options on 22 February 2013:

 

1,000,000 unlisted options exercisable at $0.15 each vesting on grant date, 22 February 2013 and expiring on 30 January 2016.

 

1,000,000 unlisted options exercisable at $0.25 each vesting 30 January 2014 and expiring on 30 January 2017.

 

 

For and on behalf of Oilex Ltd

 

Robert Ierace

Chief Financial Officer / Company Secretary

 

 

cc: Directors - MC/BMc/SB/RM

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

 

 

Appendix 3B

 

New issue announcement,application for quotation of additional securitiesand agreement

 

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

 

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005, 01/08/2012.

 

 

Name of entity

 OILEX LTD

 

ABN

50 078 652 632

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1.

+Class of +securities issued or to be issued

 

Unlisted options

2.

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

2 million

3.

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

Tranche A: 1 million unlisted options exercisable at $0.15 from the 22 February 2013 and expiring on 30 January 2016;

Tranche B: 1 million unlisted options exercisable at $0.25 from the 30 January 2014 and expiring on 30 January 2017.

 

4.

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

·; the date from which they do

·; the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·; the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Not applicable.

 

 

 

5.

Issue price or consideration

 

NIL

 

 

 

6.

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

Sign-on employee options granted to the Chief Financial Officer who commenced 30 January 2013.

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

No

6b

The date the security holder resolution under rule 7.1A was passed

6c

Number of +securities issued without security holder approval under rule 7.1

 

6d

Number of +securities issued with security holder approval under rule 7.1A

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

 

 

6f

Number of securities issued under an exception in rule 7.2

 

 

6g

If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation.

 

 

6h

If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

45,212,311

 

7.

Dates of entering +securities into uncertificated holdings or despatch of certificates

 

 

 

22 February 2013

 

 

Number

+Class

8.

Number and +class of all +securities quoted on ASX (including the securities in clause 2 if applicable)

 

 

 

 

354,748,741

 

151,923,069

 

Ordinary Shares

 

Options exercisable at 15 cents expiring 7 September 2015

 

 

Number

+Class

 

9.

Number and +class of all +securities not quoted on ASX (including the securities in clause 2 if applicable)

 

75,000

4,150,000

8,737,500

75,000

3,000,000

3,000,000

1,000,000

1,000,000

$0.50 Options due 01/08/2013

$0.30 Options due 01/07/2014

$0.37 Options due 10/11/2014

$0.63 Options due 01/08/2015

$0.15 Options due17/12/2015

$0.25 Options due 17/12/2016

$0.15 Options due 30/01/2016

$0.25 Options due 30/01/2017

 

 

 

10.

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

 

 

 

 

 Part 2 ‑ Bonus issue or pro rata issue [Item 11 to 33 - Not Applicable]

 

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of securities

(tick one)

(a)

Securities described in Part 1

(b)

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

 

 

Entities that have ticked box 34(a) [Items 35 to 42 - Not Applicable]

Additional securities forming a new class of securities

 

 

 

 

Quotation agreement

 

1. +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2. We warrant the following to ASX.

 

·; The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

·; There is no reason why those +securities should not be granted +quotation.

·; An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

·; Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

·; We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the +securities to be quoted, it has been provided at the time that we request that the +securities be quoted.

·; If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3. We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4. We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

 

 

Sign here Date: 25 February 2013

 

 

 

 

Print name: Robert Ierace

 

 

 

 

 

 

 

 

Appendix 3B - Annexure 1

 

Calculation of placement capacity under rule 7.1 and rule 7.1A for +eligible entities

Introduced 01/08/12

 

Part 1

 

Rule 7.1 - Issues exceeding 15% of capital

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

Insert number of fully paid ordinary securities on issue 12 months before date of issue or agreement to issue

253,324,885

Add the following:

• Number of fully paid ordinary securities issued in that 12 month period under an exception in rule 7.2

 

22,004 (issued 21/09/2012)

2,565 (issued 28/12/2012)

49,757 (issued 18/01/2013)

19,576 (issued 18/02/2013)

·; Number of fully paid ordinary securities issued in that 12 month period with shareholder approval

101,329,954 (issued 07/09/2012)

 

• Number of partly paid ordinary

securities that became fully paid in that 12 month period

Nil

 

Note:

• Include only ordinary securities here - other classes of equity securities cannot be added

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

Subtract the number of fully paid ordinary securities cancelled during that 12 month period

Nil

"A"

354,748,741

 

Step 2: Calculate 15% of "A"

"B"

0.15

[Note: this value cannot be changed]

Multiply "A" by 0.15

53,212,311

Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period not counting those issued:

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under rule 7.1 or rule 7.4

Note:

• This applies to equity securities, unless specifically excluded - not just ordinary securities

• Include here (if applicable ) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

6,000,000 options(issued 20/12/2012)

2,000,000 options (issued 22/02/2013)

"C"

8,000,000

Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1

"A" x 0.15

Note: number must be same as shown in Step 2

53,212,311

Subtract "C"

Note: number must be same as shown in Step 3

8,000,000

Total ["A" x 0.15] - "C"

45,212,311

[Note: this is the remaining placement capacity under rule 7.1]

Part 2

 

 

Rule 7.1A - Additional placement capacity for eligible entities

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

"A"

Note: number must be same as shown in Step 1 of Part 1

N/A

Step 2: Calculate 10% of "A"

"D"

0.10

Note: this value cannot be changed

Multiply "A" by 0.10

Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

• This applies to equity securities - not just ordinary securities

• Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• It may be useful to set out issues of securities on different dates as separate line items

"E"

 

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A

"A" x 0.10

Note: number must be same as shown in Step 2

Subtract "E"

Note: number must be same as shown in Step 3

Total ["A" x 0.10] - "E"

 

Note: this is the remaining placement capacity under rule 7.1A

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFSDFDIEFIV
Date   Source Headline
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension
28th Jan 202212:50 pmRNSAppointment of Director
28th Jan 202212:47 pmRNSDecember 2021 Quarterly Report
18th Jan 20227:13 amRNSGM – Notice of Meeting
17th Jan 202212:19 pmRNSPlacing - Issue of Securities
4th Jan 20227:00 amRNSPlacement – Issue of Securities
29th Dec 20212:29 pmRNSChange of Interests of Substantial Holder
23rd Dec 20217:00 amRNSIssue of Securities
22nd Dec 20217:00 amRNSUnmarketable Parcel Facility Update
15th Dec 20218:47 amRNSCambay Production Re-start Update
13th Dec 20213:56 pmRNSCambay Well 77H Re-Frac Funding Secured
30th Nov 20217:00 amRNSUnmarketable Parcel Facility Update
29th Nov 20217:00 amRNSResult of Annual General Meeting
11th Nov 20217:00 amRNSIssue of Shares and Section 708A(5)(e) Notice
29th Oct 202110:40 amRNSAward of Well Management Services Contract
28th Oct 20217:34 amRNSSeptember 2021 Quarterly Report
27th Oct 20217:00 amRNSNotice of AGM
4th Oct 20211:39 pmRNSAGM Date / Closing Date for Director Nominations
28th Sep 20212:06 pmRNSSecond Price Monitoring Extn
28th Sep 20212:00 pmRNSPrice Monitoring Extension
22nd Sep 20213:59 pmRNSCorporate Governance Statement
22nd Sep 20213:59 pmRNSAnnual Report 2021
17th Sep 20214:41 pmRNSSecond Price Monitoring Extn
17th Sep 20214:36 pmRNSPrice Monitoring Extension
17th Sep 202111:13 amRNSCambay Update and UK Exploration Licence P2446
7th Sep 20219:53 amRNSASX Unmarketable Parcel Share Disposal
26th Aug 20217:00 amRNSAppointment of New Company Secretary
12th Aug 20217:01 amRNSAppendix 3Y P Schwarz
12th Aug 20217:01 amRNSAppendix 3Y P Haywood
12th Aug 20217:00 amRNSIssue of Shares and Section 708A(5)(e) Notice
30th Jul 20217:00 amRNSJune 2021 Quarterly Report
21st Jul 20217:24 amRNSAIM Rule 17 Disclosure
2nd Jul 20218:15 amRNSAppointment of New CFO
25th Jun 20217:00 amRNSAppendix 3Y P Schwarz
25th Jun 20217:00 amRNSAppendix 3Y P Haywood
24th Jun 20217:00 amRNSIssue of Securities
22nd Jun 202110:48 amRNSIssue of Securities
21st Jun 202111:19 amRNSIssue of Securities
17th Jun 20218:41 amRNSAppendix 3X Roland Wessel
16th Jun 20218:30 amRNSAppointment of New CEO & Director
10th Jun 202112:05 pmRNSExecution of Cambay SPA
10th Jun 202110:13 amRNSIssue of Securities
8th Jun 20217:00 amRNSResults of General Meeting
7th Jun 20212:05 pmRNSSecond Price Monitoring Extn
7th Jun 20212:00 pmRNSPrice Monitoring Extension
28th May 20217:00 amRNSBhandut Sale Completed
21st May 20217:35 amRNSAppendix 3Y P Schwarz
21st May 20217:34 amRNSAppendix 3Y P Haywood
18th May 20217:00 amRNSGM - Notice of Meeting - Change of Venue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.